中商官网
研究报告
名臣健康（002919）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 426000000.0000 | 23416500.0000 | 23885500.0000 | 20929600.0000 | 319000000.0000 | 170000000.0000 | 149000000.0000 |
| 2014 | 559000000.0000 | 32209400.0000 | 36443500.0000 | 31786200.0000 | 383000000.0000 | 202000000.0000 | 180000000.0000 |
| 2015 | 588000000.0000 | 51241900.0000 | 50997100.0000 | 43508500.0000 | 473000000.0000 | 243000000.0000 | 230000000.0000 |
| 2016 | 596000000.0000 | 54136900.0000 | 55589400.0000 | 47409000.0000 | 517000000.0000 | 230000000.0000 | 287000000.0000 |
| 2017 | 642000000.0000 | 55709400.0000 | 55903900.0000 | 48508900.0000 | 685000000.0000 | 147000000.0000 | 538000000.0000 |
| 2018 | 546000000.0000 | 31786100.0000 | 34110600.0000 | 29660700.0000 | 699000000.0000 | 148000000.0000 | 551000000.0000 |
| 2019 | 517000000.0000 | 26958100.0000 | 26197500.0000 | 23076700.0000 | 700000000.0000 | 134000000.0000 | 565000000.0000 |
| 2020 | 681000000.0000 | 105000000.0000 | 105000000.0000 | 102000000.0000 | 879000000.0000 | 224000000.0000 | 655000000.0000 |
| 2021 | 744000000.0000 | 127000000.0000 | 128000000.0000 | 133000000.0000 | 970000000.0000 | 213000000.0000 | 758000000.0000 |
| 2022 | 945000000.0000 | -5458500.0000 | 15249500.0000 | 25388900.0000 | 1243000000.0000 | 504000000.0000 | 740000000.0000 |
| 2023 | 1638000000.0000 | 57938000.0000 | 56633600.0000 | 70364700.0000 | 1274000000.0000 | 464000000.0000 | 810000000.0000 |
| 2024 | 1380000000.0000 | 31332000.0000 | 27478800.0000 | 46717200.0000 | 1103000000.0000 | 280000000.0000 | 823000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 5.40 | 5.61 | 7.49 | 15.1400 | 1.7400 | 19.46 | 1.34 |
| 2014 | 5.72 | 6.52 | 9.52 | 19.3200 | 2.3400 | 22.58 | 1.46 |
| 2015 | 8.67 | 8.67 | 10.78 | 21.5200 | 2.1300 | 19.79 | 1.24 |
| 2016 | 8.72 | 9.33 | 10.75 | 18.0400 | 2.0900 | 27.61 | 1.15 |
| 2017 | 7.94 | 8.71 | 8.16 | 16.0900 | 2.4400 | 37.66 | 0.94 |
| 2018 | 4.03 | 6.25 | 4.88 | 5.4600 | 2.0500 | 22.32 | 0.78 |
| 2019 | 3.29 | 5.07 | 3.74 | 4.1400 | 1.8900 | 22.81 | 0.74 |
| 2020 | 13.80 | 15.42 | 11.95 | 16.7800 | 2.6300 | 6.57 | 0.77 |
| 2021 | 13.44 | 17.20 | 13.20 | 18.9600 | 2.7300 | 3.74 | 0.77 |
| 2022 | -1.80 | 1.61 | 1.23 | 3.4000 | 2.7700 | 5.10 | 0.76 |
| 2023 | 3.11 | 3.46 | 4.45 | 9.0800 | 3.2600 | 6.60 | 1.29 |
| 2024 | 1.88 | 1.99 | 2.49 | 5.7400 | 4.5600 | 4.79 | 1.25 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 53.29 | 46.71 | 1.4200 | 0.5400 |
| 2014 | 52.74 | 47.00 | 1.4900 | 0.6500 |
| 2015 | 51.37 | 48.63 | 1.6100 | 0.8200 |
| 2016 | 44.49 | 55.51 | 1.9200 | 1.1500 |
| 2017 | 21.46 | 78.54 | 4.1600 | 3.0700 |
| 2018 | 21.17 | 78.83 | 4.2000 | 1.3700 |
| 2019 | 19.14 | 80.71 | 4.5700 | 3.3500 |
| 2020 | 25.48 | 74.52 | 3.0000 | 2.3200 |
| 2021 | 21.96 | 78.14 | 3.4800 | 2.5000 |
| 2022 | 40.55 | 59.53 | 1.4400 | 0.7100 |
| 2023 | 36.42 | 63.58 | 1.9600 | 1.1700 |
| 2024 | 25.39 | 74.61 | 2.6000 | 1.8000 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 403000000.0000 | 117000000.0000 | 43222300.0000 | 2033000.0000 |
| 2014 | 527000000.0000 | 121000000.0000 | 48657100.0000 | 2002500.0000 |
| 2015 | 537000000.0000 | 100000000.0000 | 57212700.0000 | 877500.0000 |
| 2016 | 544000000.0000 | 110000000.0000 | 53074300.0000 | -1700.0000 |
| 2017 | 591000000.0000 | 126000000.0000 | 39227300.0000 | -17000.0000 |
| 2018 | 524000000.0000 | 118000000.0000 | 41089100.0000 | -1267000.0000 |
| 2019 | 500000000.0000 | 111000000.0000 | 43956800.0000 | -1044900.0000 |
| 2020 | 587000000.0000 | 74744900.0000 | 51856300.0000 | 2155000.0000 |
| 2021 | 644000000.0000 | 83331900.0000 | 71160500.0000 | 1711100.0000 |
| 2022 | 962000000.0000 | 321000000.0000 | 82425100.0000 | 956200.0000 |
| 2023 | 1587000000.0000 | 665000000.0000 | 110000000.0000 | 1923500.0000 |
| 2024 | 1354000000.0000 | 444000000.0000 | 106000000.0000 | 604200.0000 |